Controversies in the treatment of pediatric victims of crotalinae snake envenomation

Clinical Pediatric Emergency Medicine

Volumn 2, Issue 3, 2001, Pages 192-202

  Bond, G Randall ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Emergency Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM ANTISERUM;

ADOLESCENT; ARTICLE; CHILD; CLINICAL OBSERVATION; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG COST; ENVENOMATION; EXCISION; FASCIOTOMY; FEMALE; FIRST AID; HUMAN; MALE; PEDIATRICS; PROPHYLAXIS; RISK; RISK BENEFIT ANALYSIS; SAFETY; SNAKE; SNAKEBITE; SURGEON; TISSUE INJURY;

EID: 0035186375     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-8401(01)90005-9     Document Type: Article

References (93)

1. Rattlesnake bites in southern California and rationale for recommended treatment
2. Snake venom poisoning
3. Snake venom poisoning
4. Deaths resulting from animal attacks in the United States
5. The legitimacy of rattlesnake bites in Central Arizona
6. Early debridement in pit viper bites
7. The 1999 annual report of the American Association of Poison Control Centers' Toxic Exposures Surveillance System
8. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in central Arizona
9. Fatal rattlesnake envenomation in Arizona: 1969-1984
10. Analysis of 460 fatalities from venomous animal in the United States
11. An epidemiological and clinical study of snake bites in childhood
12. Timber rattlesnake venom-induced myokymia: Evidence for a peripheral nerve origin
13. Fatal rattlesnake bite in a child
14. Death from a rattlesnake bite
15. Complications of Crotalidae antivenin therapy
16. Snakebite treatment in the United States
17. Treatment of venomous snakebite in the United States
18. Negative pressure suction in field treatment of rattlesnake bite
19. Effects of negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model
20. First-aid treatment of poisonous snakebite: Are currently recommended procedures justified?
21. Reptile Envenomations
22. Snakebite management: Which approach to use
23. Fang tip spread, puncture distance and suction for snake bite
24. Effects of constriction bands on rattlesnake venom absorption: A pharmacokinetic model
25. Tourniquet ineffectiveness to reduce the severity of envenoming after Crotalus durissus snake bite in Belo Horizonte
26. Rationalization of first-aid measures for elapid snakebite
27. Australian work in first-aid of poisonous snakebite
28. First-aid for snake bite
29. Sea snake envenomation at Bondi
30. High voltage shock treatment for snake bite
31. Snake envenomation
32. The effect of an electrical current on snake venom toxicity
33. Electric shocks are ineffective in treatment of lethal effects of rattlesnake envenomation in mice
34. Electric shock does not save snakebitten rats
35. Snakebites and shocks
36. Failure of electric shock treatment for rattlesnake envenomation
37. The six hour observation rule for grade I crotalid envenomation: Is it sufficient? Case report of delayed envenomation
38. Severe toxicity from Crotalid envenomation after early resolution of symptoms
39. Crotalidae envenomation in children
40. Reliability of clinical presentation for predicting significant pit viper envenomation
41. Bacteriology of rattlesnake venom and implications for therapy
42. The incidence of wound infection following Crotalid envenomation
43. Antibiotics are rarely required following rattlesnake envenomation
44. Antibiotic use and infection in snakebite victims
45. Antibacterial activity of Crotalid venom against oral snake flora and other clinical bacteria
46. Treatment of rattlesnake bites
47. The management of upper extremity pit viper wounds
48. Tissue necrosis in snakebite
49. Treatment of poisonous snakebite with emphasis on digit dermotomy
50. Pit viper bites: Rational management in locales in which copperheads and cottonmouths dominate
51. Envenomation coagulopathy in wounds from pit vipers
52. Envenomation coagulopathy from snake bites
53. New Mexico rattlesnake bites: Demographic review and guidelines for treatment
54. Treating the snakebitten child in North America: A study of pit viper bites
55. Poisonous snakebite in Utah
56. Noninvasive vascular studies in management of rattlesnake envenomations to extremities
57. Snake venom poisoning in the United States. Experience with 550 cases
58. Envenomation coagulopathy from snake bites
59. The management of snake and spider bites in the Southeastern United States
60. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment of Crotaline snakebite in the United States
61. Efficacy, safety and use of snake antivenom in the United States
62. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning
63. The treatment of crotalid envenomation without antivenin
64. Conservative treatment of copper-head snakes without antivenin
65. Role of surgical intervention in the management of Crotaline snake envenomation
66. Rattlesnake bites and surgical decompression: Results using a laboratory model
67. Edema associated with venomous snake bite
68. Diagnosis and management of compartmental syndromes
69. Upper extremity compartment syndromes following pit viper envenomation
70. Rattlesnake bites: Current hospital therapy
71. Resolution of elevated compartment pressures after rattlesnake envenomation with antivenin
72. Skin testing: Implications in the management of pit viper envenomation
73. Antivenom treatment in snake bites
74. Thrombocytopenia following timber rattlesnake envenomation
75. Mojave rattlesnake envenomation: Prolonged neurotoxicity and rhabdomyolysis
76. Successful treatment of Crotalid-induced neurotoxicity with a new polyspecific Crotalid Fab antivenom
77. Efficacy of Wyeth polyvalent antivenin used in the pretreatment of copperhead envenomation in mice
78. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial anti-venin for protection against venom induced lethality in mice
79. Relationship of venom effects to venom antigen and antivenom serum concentration in a patient with Crotalus atrox envenomation treated with a Fab antivenom
80. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and relate antibodies
81. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Guidelines for clinical management with Crotaline antivenom
82. Validation of a severity score for the assessment of Crotalid snakebite
83. DIC-like syndrome after envenomation by the snake, Crotalus horridus horridus
84. Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox)
85. Envenomation by the northern blacktail rattlesnake (Crotalus molossus molossus): Report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation
86. Pathogenesis of hemorrhage induced by rattlesnake venom
87. Successful treatment with antivenom of marked thrombocytopenia without significant coagulopathy following rattlesnake bite
88. Envenomation by the Mojave rattle-snake (Crotalus scutulatus scutulatus) in Southern Arizona, USA
89. Neutralization of Crotalidae induced platelet aggregation by affinity chromatography isolated IgG to Crotalus viridis helleri venom
90. Effect of a rattlesnake venom (Crotalus viridis helleri) on bone marrow
91. Profound thrombocytopenia associated with Crotalus ruber ruber envenomation: A clinical case
92. Rattlesnake venom-induced thrombocytopenia response to antivenin (Crotalidae) polyvalent: A case series
93. Snake venom coagulopathy: Use and abuse of blood products in the treatment of pit viper envenomation